1. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Issue 10249 (15th August 2020) Authors: Folegatti, Pedro M; Ewer, Katie J; Aley, Parvinder K; Angus, Brian; Becker, Stephan; Belij-Rammerstorfer, Sandra; Bellamy, Duncan; Bibi, Sagida; Bittaye, Mustapha; Clutterbuck, Elizabeth A; Dold, Christina; Faust, Saul N; Finn, Adam; Flaxman, Amy L; Hallis, Bassam; Heath, Paul; Jenkin, Daniel; La... Journal: Lancet Issue: Volume 396:Issue 10249(2020) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. Issue 9 (September 2022) Authors: Abhishek, Abhishek; Boyton, Rosemary J; Peckham, Nicholas; McKnight, Áine; Coates, Laura C; Bluett, James; Barber, Vicki; Cureton, Lucy; Francis, Anne; Appelbe, Duncan; Eldridge, Lucy; Julier, Patrick; Valdes, Ana M; Brooks, Tim; Rombach, Ines; Altmann, Daniel M; Nguyen-Van-Tam, Jonathan S; Willi... Journal: Lancet Issue: Volume 10:Issue 9(2022) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lupus, vaccinations and COVID-19: What we know now. (September 2021) Authors: Mason, Alice; Anver, Himashi; Lwin, May; Holroyd, Christopher; Faust, Saul N; Edwards, Christopher J Journal: Lupus Issue: Volume 30:Number 10(2021) Page Start: 1541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O35 Efficacy & safety of tocilizumab in GCA: a multi-centre experience of NHS clinical practice. (20th April 2020) Authors: Sebastian, Alwin; Kayani, Abdul; Ranasinghe, Chavini; Hall, Frances; Ransom, Colin; Jayne, David; Quick, Vanessa; Hughes, Mark; Stack, John; Mukhtyar, Chetan; Coath, Fiona; Bharadwaj, Anurag; Hajela, Vijay; Butler, Stephanie; Lwin, May; Edwards, Christopher; Whitlock, Madeline; Dasgupta, Bhaskar Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Are Primetime Diets Congruent With Dietary Recommendations? Content Analyses of Food Advertisements in the United States, China, and Singapore. (1st January 2016) Authors: Yeo, Su Lin; Shin, Wonsun; Lwin, May; Williams, Jerome; Hong, Ying-Yi Journal: Global health communication Issue: Volume 2(2016) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Does COVID-19 cause an increased risk of hospitalization or death in patients with inflammatory rheumatic diseases treated with biological DMARDs or targeted synthetic DMARDs?. Issue 2 (21st October 2020) Authors: Lwin, May; Holroyd, Christopher; Wallis, Dinny; Davidson, Brian; Goulston, Lyndsey; de Graaf, Hans; Edwards, Christopher J Journal: Rheumatology advances in practice Issue: Volume 4:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Are Primetime Diets Congruent With Dietary Recommendations? Content Analyses of Food Advertisements in the United States, China, and Singapore. (1st January 2016) Authors: Yeo, Su Lin; Shin, Wonsun; Lwin, May; Williams, Jerome; Hong, Ying-Yi Journal: Global health communication Issue: Volume 2(2016) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗